Financhill
Sell
49

MRM Quote, Financials, Valuation and Earnings

Last price:
$1.60
Seasonality move :
-8.69%
Day range:
$1.55 - $1.69
52-week range:
$0.34 - $8.39
Dividend yield:
0%
P/E ratio:
8.10x
P/S ratio:
0.18x
P/B ratio:
2.19x
Volume:
50.4K
Avg. volume:
591.2K
1-year change:
-67.65%
Market cap:
$13M
Revenue:
$54.9M
EPS (TTM):
-$0.12

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MRM
MEDIROM Healthcare Technologies
-- -- -- -- $4.98
HMC
Honda Motor
$37.5B -- 5% -- $36.76
LGCB
Linkage Global
-- -- -- -- --
NPSKY
NSK
-- -- -- -- --
TKLF
Tokyo Lifestyle
-- -- -- -- --
TM
Toyota Motor
$83.6B -- 8.42% -- $225.82
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MRM
MEDIROM Healthcare Technologies
$1.65 $4.98 $13M 8.10x $0.00 0% 0.18x
HMC
Honda Motor
$29.18 $36.76 $40.4B 8.35x $0.71 4.75% 0.32x
LGCB
Linkage Global
$2.41 -- $7.4M -- $0.00 0% 0.50x
NPSKY
NSK
$8.98 -- $2.2B 31.38x $0.23 5.15% 0.42x
TKLF
Tokyo Lifestyle
$3.78 -- $16M 1.82x $0.00 0% 0.07x
TM
Toyota Motor
$181.99 $225.82 $237.2B 7.74x $3.46 3.33% 0.76x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MRM
MEDIROM Healthcare Technologies
129.27% 7.475 51.51% 0.23x
HMC
Honda Motor
-- -0.963 -- 1.00x
LGCB
Linkage Global
18.89% -1.277 2.68% 0.70x
NPSKY
NSK
-- 0.140 -- 1.44x
TKLF
Tokyo Lifestyle
62.9% 0.266 269.64% 1.08x
TM
Toyota Motor
51.92% -0.590 109.51% 1.06x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MRM
MEDIROM Healthcare Technologies
-- -- -6.44% -- -- --
HMC
Honda Motor
$7.5B $482.4M 5.97% 6.34% 2.03% -$990.6M
LGCB
Linkage Global
-- -- -29.38% -42.09% -- --
NPSKY
NSK
$271.2M $25.2M 1.54% 1.55% 3.42% -$21.3M
TKLF
Tokyo Lifestyle
-- -- 6.96% 19.93% -- --
TM
Toyota Motor
$15.3B $7.3B 6.39% 13.1% 8.2% $605.5M

MEDIROM Healthcare Technologies vs. Competitors

  • Which has Higher Returns MRM or HMC?

    Honda Motor has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of 0.57%. MEDIROM Healthcare Technologies's return on equity of -- beat Honda Motor's return on equity of 6.34%.

    Company Gross Margin Earnings Per Share Invested Capital
    MRM
    MEDIROM Healthcare Technologies
    -- -- $7.7M
    HMC
    Honda Motor
    21.23% $0.18 $84.4B
  • What do Analysts Say About MRM or HMC?

    MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 202.09%. On the other hand Honda Motor has an analysts' consensus of $36.76 which suggests that it could grow by 25.96%. Given that MEDIROM Healthcare Technologies has higher upside potential than Honda Motor, analysts believe MEDIROM Healthcare Technologies is more attractive than Honda Motor.

    Company Buy Ratings Hold Ratings Sell Ratings
    MRM
    MEDIROM Healthcare Technologies
    1 0 0
    HMC
    Honda Motor
    2 0 0
  • Is MRM or HMC More Risky?

    MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Honda Motor has a beta of 0.505, suggesting its less volatile than the S&P 500 by 49.457%.

  • Which is a Better Dividend Stock MRM or HMC?

    MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Honda Motor offers a yield of 4.75% to investors and pays a quarterly dividend of $0.71 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. Honda Motor pays out 41.61% of its earnings as a dividend. Honda Motor's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MRM or HMC?

    MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than Honda Motor quarterly revenues of $35.2B. MEDIROM Healthcare Technologies's net income of -- is lower than Honda Motor's net income of $200.5M. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 8.10x while Honda Motor's PE ratio is 8.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.18x versus 0.32x for Honda Motor. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MRM
    MEDIROM Healthcare Technologies
    0.18x 8.10x -- --
    HMC
    Honda Motor
    0.32x 8.35x $35.2B $200.5M
  • Which has Higher Returns MRM or LGCB?

    Linkage Global has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of --. MEDIROM Healthcare Technologies's return on equity of -- beat Linkage Global's return on equity of -42.09%.

    Company Gross Margin Earnings Per Share Invested Capital
    MRM
    MEDIROM Healthcare Technologies
    -- -- $7.7M
    LGCB
    Linkage Global
    -- -- $8.3M
  • What do Analysts Say About MRM or LGCB?

    MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 202.09%. On the other hand Linkage Global has an analysts' consensus of -- which suggests that it could fall by --. Given that MEDIROM Healthcare Technologies has higher upside potential than Linkage Global, analysts believe MEDIROM Healthcare Technologies is more attractive than Linkage Global.

    Company Buy Ratings Hold Ratings Sell Ratings
    MRM
    MEDIROM Healthcare Technologies
    1 0 0
    LGCB
    Linkage Global
    0 0 0
  • Is MRM or LGCB More Risky?

    MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Linkage Global has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock MRM or LGCB?

    MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Linkage Global offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. Linkage Global pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MRM or LGCB?

    MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than Linkage Global quarterly revenues of --. MEDIROM Healthcare Technologies's net income of -- is lower than Linkage Global's net income of --. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 8.10x while Linkage Global's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.18x versus 0.50x for Linkage Global. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MRM
    MEDIROM Healthcare Technologies
    0.18x 8.10x -- --
    LGCB
    Linkage Global
    0.50x -- -- --
  • Which has Higher Returns MRM or NPSKY?

    NSK has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of 0.99%. MEDIROM Healthcare Technologies's return on equity of -- beat NSK's return on equity of 1.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    MRM
    MEDIROM Healthcare Technologies
    -- -- $7.7M
    NPSKY
    NSK
    20.76% $0.05 $4.5B
  • What do Analysts Say About MRM or NPSKY?

    MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 202.09%. On the other hand NSK has an analysts' consensus of -- which suggests that it could fall by --. Given that MEDIROM Healthcare Technologies has higher upside potential than NSK, analysts believe MEDIROM Healthcare Technologies is more attractive than NSK.

    Company Buy Ratings Hold Ratings Sell Ratings
    MRM
    MEDIROM Healthcare Technologies
    1 0 0
    NPSKY
    NSK
    0 0 0
  • Is MRM or NPSKY More Risky?

    MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NSK has a beta of 0.407, suggesting its less volatile than the S&P 500 by 59.278%.

  • Which is a Better Dividend Stock MRM or NPSKY?

    MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NSK offers a yield of 5.15% to investors and pays a quarterly dividend of $0.23 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. NSK pays out 146.95% of its earnings as a dividend.

  • Which has Better Financial Ratios MRM or NPSKY?

    MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than NSK quarterly revenues of $1.3B. MEDIROM Healthcare Technologies's net income of -- is lower than NSK's net income of $12.9M. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 8.10x while NSK's PE ratio is 31.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.18x versus 0.42x for NSK. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MRM
    MEDIROM Healthcare Technologies
    0.18x 8.10x -- --
    NPSKY
    NSK
    0.42x 31.38x $1.3B $12.9M
  • Which has Higher Returns MRM or TKLF?

    Tokyo Lifestyle has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of --. MEDIROM Healthcare Technologies's return on equity of -- beat Tokyo Lifestyle's return on equity of 19.93%.

    Company Gross Margin Earnings Per Share Invested Capital
    MRM
    MEDIROM Healthcare Technologies
    -- -- $7.7M
    TKLF
    Tokyo Lifestyle
    -- -- $105.8M
  • What do Analysts Say About MRM or TKLF?

    MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 202.09%. On the other hand Tokyo Lifestyle has an analysts' consensus of -- which suggests that it could fall by --. Given that MEDIROM Healthcare Technologies has higher upside potential than Tokyo Lifestyle, analysts believe MEDIROM Healthcare Technologies is more attractive than Tokyo Lifestyle.

    Company Buy Ratings Hold Ratings Sell Ratings
    MRM
    MEDIROM Healthcare Technologies
    1 0 0
    TKLF
    Tokyo Lifestyle
    0 0 0
  • Is MRM or TKLF More Risky?

    MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tokyo Lifestyle has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock MRM or TKLF?

    MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tokyo Lifestyle offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. Tokyo Lifestyle pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MRM or TKLF?

    MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than Tokyo Lifestyle quarterly revenues of --. MEDIROM Healthcare Technologies's net income of -- is lower than Tokyo Lifestyle's net income of --. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 8.10x while Tokyo Lifestyle's PE ratio is 1.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.18x versus 0.07x for Tokyo Lifestyle. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MRM
    MEDIROM Healthcare Technologies
    0.18x 8.10x -- --
    TKLF
    Tokyo Lifestyle
    0.07x 1.82x -- --
  • Which has Higher Returns MRM or TM?

    Toyota Motor has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of 5.38%. MEDIROM Healthcare Technologies's return on equity of -- beat Toyota Motor's return on equity of 13.1%.

    Company Gross Margin Earnings Per Share Invested Capital
    MRM
    MEDIROM Healthcare Technologies
    -- -- $7.7M
    TM
    Toyota Motor
    18.86% $3.38 $505.7B
  • What do Analysts Say About MRM or TM?

    MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 202.09%. On the other hand Toyota Motor has an analysts' consensus of $225.82 which suggests that it could grow by 24.09%. Given that MEDIROM Healthcare Technologies has higher upside potential than Toyota Motor, analysts believe MEDIROM Healthcare Technologies is more attractive than Toyota Motor.

    Company Buy Ratings Hold Ratings Sell Ratings
    MRM
    MEDIROM Healthcare Technologies
    1 0 0
    TM
    Toyota Motor
    2 1 0
  • Is MRM or TM More Risky?

    MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Toyota Motor has a beta of 0.643, suggesting its less volatile than the S&P 500 by 35.685%.

  • Which is a Better Dividend Stock MRM or TM?

    MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Toyota Motor offers a yield of 3.33% to investors and pays a quarterly dividend of $3.46 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. Toyota Motor pays out 23.76% of its earnings as a dividend. Toyota Motor's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MRM or TM?

    MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than Toyota Motor quarterly revenues of $81.1B. MEDIROM Healthcare Technologies's net income of -- is lower than Toyota Motor's net income of $4.4B. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 8.10x while Toyota Motor's PE ratio is 7.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.18x versus 0.76x for Toyota Motor. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MRM
    MEDIROM Healthcare Technologies
    0.18x 8.10x -- --
    TM
    Toyota Motor
    0.76x 7.74x $81.1B $4.4B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is MSTR Stock Fundamentally Misunderstood?
Is MSTR Stock Fundamentally Misunderstood?

Software firm turned Bitcoin treasury Strategy (NASDAQ:MSTR) has made waves…

Is Alphabet or Amazon the Better Buy?
Is Alphabet or Amazon the Better Buy?

Alphabet (NASDAQ:GOOG) and Amazon (NASDAQ:AMZN) are two of the mega-cap…

Why Did Ken Griffin Buy Sweetgreen Stock?
Why Did Ken Griffin Buy Sweetgreen Stock?

In Q1, Ken Griffin’s Citadel Advisors purchased nearly 1.3 million…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
20
KARO alert for Jun 13

Karooooo [KARO] is down 20.19% over the past day.

Sell
18
OXM alert for Jun 13

Oxford Industries [OXM] is down 13.91% over the past day.

Sell
46
CRMT alert for Jun 13

America's Car-Mart [CRMT] is down 13.44% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock